• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Diabetes

Sernova touts data on implantable cell pouch for treating insulin-dependent diabetes

June 7, 2022 By Sean Whooley

Sernova announced clinical data supporting the potential of its Cell Pouch system as a “functional cure” for insulin-dependent diabetes. London, Ontario-based Sernova designed its proprietary Cell Pouch system as an implantable and scalable medical device that forms a natural environment in the body for long-term survival and function of therapeutic cells that release necessary proteins or […]

Filed Under: Clinical Trials, Diabetes, Drug-Device Combinations Tagged With: Sernova Inc

Dexcom CEO expects ‘science boom’ with CGM, automated insulin delivery

June 7, 2022 By Sean Whooley

With the G7 nearing FDA clearance, Dexcom leadership foresees major innovations for integrated automated insulin delivery down the line. Kevin Sayer began thinking about automated insulin delivery all the way back in 1994 when he was working at MiniMed. Nearly 30 years later, as CEO of Dexcom (Nasdaq:DXCM), that space continues to pique his interest. In the […]

Filed Under: Business/Financial News, Clinical Trials, Diabetes, Drug Pumps, Drug-Device Combinations, Featured, Health Technology, News Well, Patient Monitoring, Software / IT Tagged With: American Diabetes Association, Dexcom

Tandem reports positive data for t:slim X2 insulin pump with Control-IQ technology

June 6, 2022 By Sean Whooley

Tandem Diabetes Care (Nasdaq:TNDM) announced today that real-world data supports its t:slim X2 insulin pump with Control-IQ technology. Data from the ongoing real-world Control-IQ observational (CLIO) study demonstrating immediate and sustained benefits in a diverse cohort of participants was presented at the American Diabetes Association (ADA) 82nd Scientific Sessions in New Orleans. Get the full story […]

Filed Under: Clinical Trials, Diabetes, Drug Pumps, Drug-Device Combinations, Featured, Health Technology, Patient Monitoring, Software / IT Tagged With: Tandem Diabetes Care

One Drop studies show improved attitudes toward CGM, diabetes management platform

June 6, 2022 By Sean Whooley

One Drop announced positive data from multiple studies evaluating the opinions of people with diabetes on continuous glucose monitoring. New York-based One Drop presented new research about attitudes and adoption of continuous glucose monitors (CGMs) among people with type 2 diabetes at the American Diabetes Association (ADA) 82nd Scientific Sessions in New Orleans. Get the full […]

Filed Under: Clinical Trials, Diabetes, Digital Health, Health Technology, Patient Monitoring, Software / IT Tagged With: American Diabetes Association, One Drop

Virta Health reports positive results from diabetes reversal study

June 6, 2022 By Sean Whooley

Virta Health announced today that its diabetes reversal treatment demonstrated improvements in those with type 2 diabetes. San Francisco-based Virta Health launched in 2017 with the goal of reversing Type 2 diabetes using its technology platform to enable personalized remote care. Virta’s offerings include physician supervision, health coaches, an app and biomarker tracking tools, as well as […]

Filed Under: Clinical Trials, Diabetes, Featured, News Well Tagged With: American Diabetes Association, Virta Health

Bigfoot Biomedical’s Bigfoot Unity demonstrates strong glycemic control in Type 2 diabetes

June 6, 2022 By Sean Whooley

Bigfoot Biomedical announced data supporting the use of its Bigfoot Unity system for improving glycemic control in those with diabetes. Data from a real-world retrospective analysis suggests that, for those on multiple daily injections (MDI) of insulin, Bigfoot Unity has the potential to provide rapid and durable glycemic control improvements. Milpitas, California–based Bigfoot presented the real-world […]

Filed Under: Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Health Technology, News Well, Patient Monitoring, Software / IT Tagged With: Bigfoot Biomedical

Late-breaking data supports Abbott FreeStyle Libre 3 in 14-day glucose monitoring

June 6, 2022 By Sean Whooley

Abbott (NYSE:ABT) announced data demonstrating the accuracy of its next-generation FreeStyle Libre 3 continuous glucose monitor (CGM). The latest version of the company’s FreeStyle Libre platform — designed as the smallest and thinnest CGM sensor in the world at the size of just two stacked U.S. pennies — picked up FDA clearance for people with diabetes aged […]

Filed Under: Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Health Technology, Patient Monitoring, Software / IT Tagged With: Abbott, American Diabetes Association

Insulet’s Omnipod 5 “significantly improves” glycemic outcomes in very young children

June 6, 2022 By Sean Whooley

Insulet (Nasdaq:PODD) announced data supporting the use of its Omnipod 5 automated insulin delivery system in young children. Acton, Massachusetts–based Insulet’s Omnipod 5 significantly improved time in range and reduced HbA1c in children aged 2 through 5.9 years old with type 1 diabetes over 12 months of use, according to the company. Earlier this year, the […]

Filed Under: Clinical Trials, Diabetes, Drug Pumps, Drug-Device Combinations, Featured, News Well, Patient Monitoring, Pediatrics Tagged With: Insulet

Real-world data backs Medtronic’s next-gen MiniMed 780G insulin pump

June 6, 2022 By Sean Whooley

Medtronic (NYSE:MDT) announced positive real-world data supporting its next-generation MiniMed 780G insulin pump system. Results from real-world analyses in Europe and Chile, along with clinical data, were presented by Medtronic at the American Diabetes Association (ADA) 82nd Scientific Sessions in New Orleans. According to a news release, the MiniMed 780G advanced hybrid closed loop system, designed with […]

Filed Under: Clinical Trials, Diabetes, Drug Pumps, Drug-Device Combinations, Featured, News Well, Patient Monitoring Tagged With: American Diabetes Association, Medtronic

Abbott to develop biowearable for continuous monitoring of glucose, ketone levels

June 3, 2022 By Sean Whooley

Abbott (NYSE:ABT) announced today that it is developing a new biowearable for continuously monitoring both glucose and ketone levels. The all-in-one sensor has already garnered FDA breakthrough device designation and will be used in pivotal trials in 2023, with regulatory submissions to follow thereafter. Get the full story at our sister site, Drug Delivery Business News.

Filed Under: Biotech, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Health Technology, News Well, Patient Monitoring, Pediatrics, Regulatory/Compliance Tagged With: Abbott

Study backs DarioHealth’s digital therapeutics for managing diabetes

June 3, 2022 By Sean Whooley

DarioHealth (Nasdaq:DRIO) announced today that multiple research studies support its digital therapeutics for diabetes management. New York-based DarioHealth presented the data from the new studies at the American Diabetes Association’s (ADA) 82nd Scientific Sessions in New Orleans. Two of the studies add to DarioHealth’s evidence supporting an integrated approach to managing multiple chronic conditions, while the third […]

Filed Under: Big Data, Clinical Trials, Diabetes, Digital Health, Featured, Health Technology, News Well, Patient Monitoring, Software / IT Tagged With: American Diabetes Association, DarioHealth Corp

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Interim pages omitted …
  • Go to page 122
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS